Company intelligence / Profile preview

Wiedenmann

Münsing, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Wiedemann Pharma is a German pharmaceutical company specializing in the development and production of natural medicines, homeopathic remedies, and organotherapeutic products. Founded in 1953, the company is well-known for its focus on revitalization therapies and the use of thymic peptides and organ extracts to support the immune system and treat age-related conditions. Their product portfolio includes a range of parenteral and oral medications aimed at chronic diseases, metabolic support, and general wellness. Wiedemann Pharma operates primarily in the European market, catering to practitioners of integrative and biological medicine.

Therapeutic areas: ImmunologyNeurologyOtherMetabolic Disorders
Modalities: Small moleculeBiologicPeptidesProteinHormoneVaccine
Industry: Biotech

Beyond the preview

Go deeper on Wiedenmann.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wiedenmann.

Explore the full profile